NCT04883437 2026-02-09Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin LymphomasEmory UniversityPhase 2 Recruiting49 enrolled